IQVIA Holdings Inc. (IQV) stock
IQVNYSEServices-Commercial Physical & Biological ResearchFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 27, 2026Score 9/3014% above fair value
$257.84+0.24 (+0.09%)
Close on Nov 18, 2026Market cap $42.49BP/E 31.3Yield –
Iqvia operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Iqvia's operating income for the twelve months ending Sep 30, 2026 was $2.22B, up 1.7% year over year. For fiscal 2025 it was $2.18B, down 0.9% from the year before. Over ten years it grew 12.9% a year on average. The highest annual figure on record is $2.20B in fiscal 2024.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.18B | -0.9% |
| FY2024 | Dec 31, 2024 | $2.20B | +11.4% |
| FY2023 | Dec 31, 2023 | $1.98B | +9.9% |
| FY2022 | Dec 31, 2022 | $1.80B | +29.1% |
| FY2021 | Dec 31, 2021 | $1.39B | +90.6% |
| FY2020 | Dec 31, 2020 | $731.00M | -5.9% |
| FY2019 | Dec 31, 2019 | $777.00M | +4.9% |
| FY2018 | Dec 31, 2018 | $741.00M | +11.4% |
| FY2017 | Dec 31, 2017 | $665.00M | +15.5% |
| FY2016 | Dec 31, 2016 | $576.00M | -10.8% |
| FY2015 | Dec 31, 2015 | $646.00M | +9.5% |
| FY2014 | Dec 31, 2014 | $590.00M | +27.6% |
| FY2013 | Dec 31, 2013 | $462.33M | +16.6% |
| FY2012 | Dec 31, 2012 | $396.44M | +14.8% |
| FY2011 | Dec 31, 2011 | $345.25M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $572.00M | +3.4% |
| Q2 FY2026 | Jun 30, 2026 | $506.00M | 0.0% |
| Q1 FY2026 | Mar 31, 2026 | $514.00M | +3.6% |
| Q4 FY2025 | Dec 31, 2025 | $627.00M | +0.2% |
| Q3 FY2025 | Sep 30, 2025 | $553.00M | +0.5% |
| Q2 FY2025 | Jun 30, 2025 | $506.00M | -2.7% |
| Q1 FY2025 | Mar 31, 2025 | $496.00M | -2.0% |
| Q4 FY2024 | Dec 31, 2024 | $626.00M | +25.0% |
| Q3 FY2024 | Sep 30, 2024 | $550.00M | +14.3% |
| Q2 FY2024 | Jun 30, 2024 | $520.00M | -0.8% |
| Q1 FY2024 | Mar 31, 2024 | $506.00M | +7.4% |
| Q4 FY2023 | Dec 31, 2023 | $501.00M | +32.2% |
| Q3 FY2023 | Sep 30, 2023 | $481.00M | +1.9% |
| Q2 FY2023 | Jun 30, 2023 | $524.00M | +15.7% |
| Q1 FY2023 | Mar 31, 2023 | $471.00M | -4.8% |
| Q4 FY2022 | Dec 31, 2022 | $379.00M | -18.1% |
| Q3 FY2022 | Sep 30, 2022 | $472.00M | +56.3% |
| Q2 FY2022 | Jun 30, 2022 | $453.00M | +58.4% |
| Q1 FY2022 | Mar 31, 2022 | $495.00M | +44.7% |
| Q4 FY2021 | Dec 31, 2021 | $463.00M | +60.2% |
| Q3 FY2021 | Sep 30, 2021 | $302.00M | +61.5% |
| Q2 FY2021 | Jun 30, 2021 | $286.00M | +361.3% |
| Q1 FY2021 | Mar 31, 2021 | $342.00M | +77.2% |
| Q4 FY2020 | Dec 31, 2020 | $289.00M | +74.1% |
| Q3 FY2020 | Sep 30, 2020 | $187.00M | -8.3% |
| Q2 FY2020 | Jun 30, 2020 | $62.00M | -68.5% |
| Q1 FY2020 | Mar 31, 2020 | $193.00M | -8.1% |
| Q4 FY2019 | Dec 31, 2019 | $166.00M | -19.8% |
| Q3 FY2019 | Sep 30, 2019 | $204.00M | +12.7% |
| Q2 FY2019 | Jun 30, 2019 | $197.00M | +15.9% |
| Q1 FY2019 | Mar 31, 2019 | $210.00M | +14.8% |
| Q4 FY2018 | Dec 31, 2018 | $207.00M | +45.8% |
| Q3 FY2018 | Sep 30, 2018 | $181.00M | -7.2% |
| Q2 FY2018 | Jun 30, 2018 | $170.00M | +34.9% |
| Q1 FY2018 | Mar 31, 2018 | $183.00M | -9.4% |
| Q4 FY2017 | Dec 31, 2017 | $142.00M | -1.4% |
| Q3 FY2017 | Sep 30, 2017 | $195.00M | – |
| Q2 FY2017 | Jun 30, 2017 | $126.00M | – |
| Q1 FY2017 | Mar 31, 2017 | $202.00M | – |
| Q4 FY2016 | Dec 31, 2016 | $144.00M | – |
See a number that looks wrong?